AirMarshall Posted April 11, 2008 Share Posted April 11, 2008 Bloomburg News: http://www.bloomberg.com/apps/news?pid=206...Ow&refer=us The US patent on Risperdal expires June 29th, 2008. Several companies including Teva Pharmaceuticals and Maylan have been fighting over first approval. The FDA was going to grant permission simultaneously to all generic companies. Unfortunately, a US court has ordered that Teva will have 6 months of exclusive marketing, meaning we will have to wait till next winter for true price competition. a.m. Link to comment Share on other sites More sharing options...
Recommended Posts
Archived
This topic is now archived and is closed to further replies.